http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104402818-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D219-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D219-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2014-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104402818-B |
| titleOfInvention | A kind of compound or pharmaceutically acceptable salt thereof with tumour response release medicine and preparation, application |
| abstract | A kind of compound or pharmaceutically acceptable salt thereof with tumour response release medicine and preparation, application, belong to drug targeting release tech field, and its structural formula is as follows: Present invention design, a kind of novel tumor cellular sensitivity compound of synthesis, it can stable existence in normal physiological context, after entering tumour cell, in tumour cell, cascade reaction can occur under high concentration glutathione environment thus discharge amsacrine medicine, can be used for preparing novel targeted antineoplastic.Additionally, the preparation method of compound of the present invention has easy and simple to handle, mild condition, reaction yield high. |
| priorityDate | 2014-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.